StockData

Infleqtion vs SOPHiA GENETICS

INFQ and SOPH side by side, both in computer programming, data processing, and other computer related services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How INFQ and SOPH compare

SOPHiA GENETICS keeps more of each dollar of sales as profit, with a net margin of −102% compared with −198% at Infleqtion.

Infleqtion scores higher on the StockData Score (7 against 4 for SOPHiA GENETICS), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricINFQSOPH
Size and price
Market cap$1.8B–
Share price$7.90$7.44
Change, 1 year−50.8%69.9%
Change, 5 years–−48.5%
Beta (5Y)3.281.83
Employees205415
StockData Score
Total score7 (better)4
Valuation score00
Growth score12 (better)
Performance score01 (better)
Health score6 (better)1
Dividend score00
Valuation
P/S41.5×–
P/B3.1×–
Growth
Revenue growth (TTM)–18.6%
Revenue growth, 5Y average–22.2%
Profitability
Gross margin16.4%67.4% (better)
Operating margin−254%−91.8% (better)
Net margin−198%−102% (better)
FCF margin–−47.2%
Return on equity−46.9%–
Financial health
Debt / equity0.00–
Interest coverage–−15.6×
Current ratio8.66 (better)2.69
Altman Z-score13.92–
Piotroski F-score6 (better)2
Dividends and buybacks
Shareholder yield0.00%–
Ownership
Held by institutions40.9%–
Held by insiders10.3%11.0%
Insider net buying, 12 months−$541M−$4.9M (better)
Superinvestors holding1–
Short interest, % of float14.9%1.9%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.